3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
10
Gastrointestinal
6
Head & Neck
5
Thoracic
3
Sarcoma
2
Lymphoid
2
Classical hematology
2
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Sarcoma
266
Osteosarcoma
81
Sarcoma, Ewing
50
Neoplasms
43
Melanoma
43
Gastrointestinal Stromal Tumors
43
Colorectal Neoplasms
40
Breast Neoplasms
37
Bone Neoplasms
37
Rhabdomyosarcoma
35
Neoplasm Metastasis
32
Pancreatic Neoplasms
30
Ovarian Neoplasms
30
Neuroblastoma
30
Stomach Neoplasms
28
Dendritic Cell Sarcoma, Interdigitating
27
Lung Neoplasms
26
Liposarcoma
25
Leiomyosarcoma
25
Glioblastoma
23
Uterine Cervical Neoplasms
22
Carcinoma, Non-Small-Cell Lung
22
Sarcoma, Synovial
21
Head and Neck Neoplasms
21
Esophageal Neoplasms
21
Sarcoma, Kaposi
19
Lymphoma
18
Carcinoma, Hepatocellular
18
Urinary Bladder Neoplasms
17
Prostatic Neoplasms
17
Interventions
Standard of Care
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
STA 9090
1
SGN-LIV1A
1
Paclitaxel
1
MK 2206
1
Letrozole
1
Lasofoxifene
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Pathologic Complete Response
×
Sarcoma
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled